chrisvoncsefalvay/vaers-outcomes huggingface dataset:
following his first vaccine dose he had pressure "in the middle of his lower rib cage" in the front States he "felt pressure"; felt like gas; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A male patient in his 40's received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: DISCOMFORT (non-serious), outcome "unknown", described as "following his first vaccine dose he had pressure "in the middle of his lower rib cage" in the front States he "felt pressure""; ABDOMINAL DISTENSION (non-serious), outcome "unknown", described as "felt like gas".  Clinical course: Male in his late 40's. He states that the day following his first vaccine dose he had pressure "in the middle of his lower rib cage" in the front. States he "felt pressure", "could not get comfortable", that it "felt like gas". Stated it was gone within 24 hours and he had no other symptoms.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Muscle aches in waist, legs, arms. Burning skin all over body painful by touching. Fever and headache, chills. Very sensitive skin. Pains even washing hands. 36 hrs.
pt recvd vax 3MAR93 & 2 days following vax pt devel redness & swelling @ inject site that extended to wrist; also exp itching & stinging @ the inject site; @ the time of the report pt had recovered;
I had positional vertigo, I called made an appointment with my physician. I had two physical therapy appointments; I also had the Epley maneuver that helped to resolve the vertigo. The vertigo is gone and has not returned.
Pt presented today for first covid 19 vaccine. At 11:59 am (14 minutes) pt reports feeling nauseated and having sharp pain on left side of shoulder that radiates to neck. Pt indicated that this pain was new. Pt then tilted head back and eyes rolled. Pt reported feeling hot and stated she felt drunk. Pt also reports sob. Denies any constriction of throat. No labored breathing noted. Respirations normal, O2 at 2 liters applied. Doctor made aware and presented at pt's side. Vitals obtained. Pt reported to Doctor that pain is gone. Continues to report feeling weak and shaky. Blood sugar 126. Doctor offered pt juice and crackers if needed. Pt indicated she is okay at this time. O2 remained in place. Will continue monitoring pt.
After the first dose he complained of bloody stool, severe vomiting, high fever and flu-like symptoms.   His symptoms occurred within a few hours of receiving his first dose and lasted approximately 21 days. He said he felt ?run down,? and similar feelings of dehydration and exhaustion.  He had the above side effects with second dose but complained that the magnitude of symptoms were much worse and bloody stool increased. He complained of feeling as if he was going to ?pass out,? upon instances of brief aerobic activity.   Upon the
elevated blood pressure; some pain and tenderness to the immunization site; very fatigued; bad headache; left eye sensitive to light; sensitivity to voices; sore throat; eye twitching; 0.5 ML; This is a spontaneous report from a contactable nurse (patient). A 64-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Deltoid Left on 20Sep2021 17:30 (Batch/Lot Number: FF2587) as DOSE 1, 0.5 ML SINGLE for covid-19 immunisation. Medical history included ongoing hypertension diagnosed when she was 40. There were no concomitant medications. The patient had flu shot for immunization and experienced arm soreness. Caller stated she received her first dose of the vaccine on Monday 20Sep2021, On 21Sep2021, the patient experienced some pain and tenderness to the immunization site, very fatigued, bad headache, left eye sensitive to light and eye twitching, and sensitivity to voices. The patient stated she feels they are neurologic symptoms, and a sore throat, but this time on the right side, the other was on the left side. Confirms these symptoms are ongoing and persisting. Blood pressure is a little elevated: She has a history of high blood pressure, it has been controlled with medication, she checked it today and it was 147/83, confirms began today 23Sep2021, she has had it controlled in the past. Denies that it's ongoing. Seriousness: She confirms all symptoms reported, she would say is medically significant, like right now when she's speaking to her, she's not really sensitive to voices and now she is. The patient underwent lab tests and procedures which included blood pressure measurement: 147/83 on 23Sep2021 little elevated.  The outcome of the events some pain and tenderness to the immunization site, elevated blood pressure, and eye twitching was unknown while not recovered for the other events.; Sender's Comments: Based on the information available and close temporal association, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported events . The case will be reassessed once new information is available   The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
76 y/o 7 days post Tetanus injection presents with R) upper arm red et painful. Started on Sunday 10/14/07. no fever 97.9 BP 104/60. Keflex x 500 mg bid x 10days.
A report was received from a health professional on 10/23/2002, concerning a 30 year old female vaccinee who was inadvertently administered the Fluvirin vaccine subcutaneously on 10/23/2002.  The vaccinee did not experience any adverse event. There was insufficient information to determine the reporters causality assessment.
She developed a lump on arm and flu like symptoms and felt flu like sickness for days to follow.
Chest pain, fatigue, cough and shortness of breath. Pt. was diagnosed with COVID 2 weeks prior to arrival to hospital.
Pt reported a "line" going from the injection point down across his bicep. He said it was hot and painful to touch, but went away after a day or two.
This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age (gender unspecified). On 12-APR-2012, the patient was vaccinated with first dose of GARDASIL (lot number, expiry date and route was not reported). On 30-NOV-2012, the patient was vaccinated with second dose of GARDASIL (lot number, expiry date and route was not reported). Concomitant medications were not reported. No adverse effect was reported. Additional information is not expected.
Pt experienced hives on both arms, started at the injection site, pt prescribed dipenhydramine.
shingles; This case was reported by a consumer via call center representative and described the occurrence of shingles in a 41-year-old patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent 2020-2021 season) for prophylaxis.   On an unknown date, the patient received Influenza vaccine Quadrivalent 2020-2021 season. On an unknown date, less than a year after receiving Influenza vaccine Quadrivalent 2020-2021 season, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Influenza vaccine Quadrivalent 2020-2021 season.  Additional details were provide as follows: The patient self-reported this case. The age at vaccination was not reported. The patient received dose of flu vaccine last year and experienced shingles. The patient asked his/her insurance was not cover Shingrix since he/she was not 50 years old yet, were there other options to mitigate the cost of the vaccine. No further information reported.
High fever, full body chills, muscle aches, joint pain. All events lasted over 2-3 days. I used tylenol, drank plenty of fluids and got rest.
Immediate swelling of area locally to about the area size of a silver dollar, 1/2 inch high in center.
Patient presenting with complaint of dizziness, nausea, legs tingling.  VS at 3:20 BP: 122/72 HR:114 RR:22 02:100%   Provider assessed patient noted vasovagal response after acute stressor (vaccination). No angioedema no SOB, no hypoxia, no rash. Vitals WNL. Symptoms self resolved. Continue to monitor for 20 min.  Vitals at 3:30 BP: 117/72 HR:99 RR:14 02:100% Vitals at 3:55 BP: 103/63 HR:91 RR:12 02: 98% Patient sent home with no further complaints.
Fever 101.4, nausea, diaphoresis, body ache to the joints, headache, chills
herpes zoster; Information has been received from a lawyer regarding a case in litigation concerning a patient of unknown age and gender. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication.  On or about 06-AUG-2014, the patient was inoculated with a dose of zoster vaccine live (ZOSTAVAX) (lot number, dosage and route of administration were not provided) at a pharmacy by a healthcare provider, for the long-term prevention of shingles and/or zoster-related conditions. On an unspecified date, the patient was treated by a healthcare provider for herpes zoster. As a direct and proximate result of patient's use of the Zoster Vaccine Live(ZOSTAVAX) vaccine, patient would continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization (on unspecified dates), physician care, monitoring, treatment, medications, and supplies. At the time of report, the patient was not recovered from herpes zoster. The reporter considered the adverse events to be related to Zoster Vaccine Live(ZOSTAVAX).
adult VAQT A and it was administered to three 15 month old patients; Physicians's office accidently ordered adult VAQTA; adult VAQT A and it was administered to three 15 month old patients; no adverse reactions were reported; This spontaneous report as received from an unspecified reporter concerning a 15-month-old patient. There was no information about the patient's medical history, concurrent conditions or concomitant medication.  The practice  accidently ordered adult hepatitis a vaccine, inactivated (VAQTA) instead of pediatric dose (Product prescribing error).    On an unknown date, the patient was vaccinated with an adult dose of hepatitis a vaccine, inactivated (VAQTA) instead of pediatric dose for prophylaxis (dose,  route of administration, lot number and expiration date were not reported) (Product administered to patient of inappropriate age, Accidental overdose) .  No adverse reactions were reported per caller.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2105USA002492: US-009507513-2105USA004310:
Patient received her vaccine at Our Clinic. Patient received covid vaccine. 1 week after vaccine patient begin with a rash that she was treating with benadryl without improvement. Reporter at  Clinic. Facility were given.
This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, concurrent conditions, concomitant and historical drugs was not provided. On 18-OCT-2018, the patient was vaccinated with an expired VARIVAX lot # M038857, expiration date 14-SEP-2018 (dose, route and anatomical location were not provided) for prophylaxis. No adverse effects were reported. Sterile diluent used was lot # M037018, expiration date 01-MAY-2019.
This case was reported by a other health professional via call center representative and described the occurrence of dizziness in a 16-year-old female patient who received BEXSERO (batch number 16B601, expiry date 29th February 2020) for prophylaxis. Concomitant products included MENVEO and GARDASIL 9. On 31st August 2018, the patient received the 1st dose of BEXSERO (intramuscular) .5 ml. On 31st August 2018, less than an hour after receiving BEXSERO, the patient experienced dizziness. On an unknown date, the outcome of the dizziness was recovered/resolved. It was unknown if the reporter considered the dizziness to be related to BEXSERO. Additional details were provided as follows: On 31st August 2018, the patient received MENVEO (batch number AMAA041A, expiry date 30th October 2019) in the right deltoid. On the same day, the patient received 1st dose of GARDASIL 9 in the left deltoid. At 11:45, the patient received BEXSERO in the left arm. And within 5 minutes, the patient began to experience dizziness which resolved within 10 to 15 minutes.
irritation at the injection stie; pain at the injection stie; swelling at the injection stie; redness at the injection site; "ping pong ball" size lump on the left shoulder; This spontaneous report was received from a Health Professional via a company representative and refers to a 33-year-old female. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported.   On 17-AUG-2022, the patient received the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection  (lot #U037064 has been verified to be a valid lot number for hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast), expiration date not reported, but upon internal validation established as: 10-AUG-2024) administered as prophylaxis (strength, dose and route of administration were not provided). On 21-OCT-2022, the patient received the second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9).  On an unknown date after the second dose of the vaccine, the patient  the patient had irritation, pain, swelling and redness at the injection site and eventually developed a "ping pong ball" size lump on the left shoulder.  The outcome of the events, the action taken with the therapy and the causality assessment were not provided.
Feet and legs swelling; Hands stiff; This is a spontaneous report from a non-contactable consumer, the patient. A 56-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 17Aug2021 at 08:30 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetic. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any vaccines within four weeks prior to the vaccination. On 18Aug2021 at 05:00, the patient experienced feet and legs swelling and hands stiff. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events feet and legs swelling and hands stiff were not resolved at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
She stated she felt worse after the vaccine than when she had Covid./feeling as bad as she did; After the first dose she had cold sweats, for two nights her hair was wet and her body was wet with sweat; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 23Feb2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Covid infection" (unspecified if ongoing), notes: She had the Covid infection the end of May/ first of Jun. The patient's concomitant medications were not reported. The following information was reported: FEELING ABNORMAL (non-serious), outcome "unknown", described as "She stated she felt worse after the vaccine than when she had Covid./feeling as bad as she did "; COLD SWEAT (non-serious), outcome "unknown", described as "After the first dose she had cold sweats, for two nights her hair was wet and her body was wet with sweat".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Five days following the flu vaccine, I began to experience numbness, tingling, and burning in my Arms and hands. I had difficulty with dexterity and fine motor coordination. It then spread to my feet and legs, I had the sensation of weakness and difficulty with gait. I initially went to my primary care physician who referred me to a neurologist. The neurologist performed nerve conduction studies, ordered MRI, and did bloodwork. All were negative but my symptoms continued to progress. I got 2 more neurology opinions and more testing and was told I had neuropathy likely from the flu shot but I was given no definite diagnosis. After living with these horrible symptoms for 3 years, I sought the opinion of another neurologist who performed a skin biopsy and diagnosed me with small fiber neuropathy caused by the flu vaccine.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 33-year-old male patient received BNT162b2 (BNT162B2), on 03Jun2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 33 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: FIASP; LEVOTHYROXINE; INSULIN. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 antibody test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: Patient received paxlovid from 01Aug2022 to 05Aug2022 for Treatment of COVID-19. Patient had no known allergies. Other medical history: No.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
p/vax pt presented w/approx 40-50 varicella-like lesions;pt was afeb;the reporting MD felt that skin lesions were not related to vax;
Patient reported injection site reaction 2" x 1" red/not raised/no pain or itching just slightly red area.
Symmetrical urticarial discrete vesicular rash, covering body, inclusive of face, scalp and inner genitalia.
Information has been received on 08-OCT-2018 regarding a case in litigation from a lawyer and a female consumer of unknown age. The patient's concurrent conditions, medical history and concomitant medications are unknown. On or about 26-JUL-2012, the patient was inoculated with ZOSTAVAX (lot number and expiration unknown) unknown route at a pharmacy for routine adult health maintenance and for the long-term prevention of shingles. The vaccine did not prevent shingles as intended. On or about 26-SEP-2016, the patient was treated by a physician at a family medicine for the onset of a severe vesicular rash, which was diagnosed as shingles. The patient was prescribed acyclovir for management of his painful symptoms and chronic pain. As a direct and proximate result of the ZOSTAVAX and/or despite receiving the ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses and pain and suffering and other damages. Additional information has been requested.
HPV vaccination was administered in right deltoid. MENACTRA was administered following HPV in Left deltoid. Immediately following administration of MENACTRA, patient stated that he didn't feel well and had a syncopal episode. The episode lasted 10-15 seconds. patient then became alert and oriented-returned to baseline.
excessive sleeping; Extreme fatigue; temp 100; sore throat; loss of balance; Muscle weakness; This is a spontaneous report from a contactable nurse (patient). A 47-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL1284), via an unspecified route of administration in the left arm on 23Dec2020 12:00 at a single dose for COVID-19 immunization. The patient's medical history included COVID-diagnosis from Mar2020 that resulted in blood clots and pneumonia both on 2020, and allergies to shellfish, eggs, peanuts. The patient was not pregnant. Concomitant medications included acyclovir [aciclovir], levothyroxine sodium (SYNTHROID), apixaban (ELIQUIS), escitalopram oxalate (LEXAPRO), and bupropion hydrochloride (WELLBUTRIN). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 25Dec2020 06:00, the patient experienced extreme fatigue, temperature of 100, sore throat, loss of balance, muscle weakness, and excessive sleeping. The events resulted in doctor or other healthcare professional office/clinic visit. The patient underwent other lab tests and procedures which included COVID test nasal swab was negative on 28Dec2020. Outcome of the events was not recovered. The events were considered non-serious by the reporter.
Hives all over body; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP69SS) via an unspecified route of administration in the left arm on 27Mar2021 at 11:15 as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food or other products. The patient did not take any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 28Mar2021, the patient experienced hives all over body. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. No therapeutic measures were taken as a result of the reported event. The clinical outcome of the event hives was not resolved.   No follow-up attempts are possible. No further information is expected.
Felt SOB immediately with injections, then chest tightness x5 days. "Weak" legs x2wks-strength intact on exam, normal exam. "Achy". Went to ER x2 (11/21/09, 11/24/09), Student Health Clinic 12/2/09.
pt recv vax 19MAY98 & presented to treatment room on 20MAY 1PM w/ c/o swelling on rt upper arm-large amount of edema present w/redness;states redness began posterior aspect of arm where recv meningococcal vax;
20 minutes after the vaccine noted a burning sensation near sternum.  Used a heating pad bc later it started to hurt (felt like someone poked her really hard)   Discomfort on the sternum has resolved  On the 18th felt a burning sensation  No rashes noted  Feeling burning sensation bilaterally around ears (6/10)  20 minutes after the vaccine noted a burning sensation near sternum.  Used a heating pad bc later it started to hurt (felt like someone poked her really hard)   Discomfort on the sternum has resolved  On the 18th felt a burning sensations all over that would last briefly  No rashes noted  Feeling burning sensation bilaterally around ears (6/10 pain) worse on the L   No SOB No rash  No throat or mouth swelling  No wheezing  No N/V